Elanco Animal Health Incorporated (ELAN) reported $1.21 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 4.1$0.34 for the same period compares to $0.45 a year ago. The reported revenue compares to the Zacks Consensus Estimate of$1.17 billion, representing a surprise of +2.69%. The company delivered an EPS surprise of +30.77%, with the consensus EPS estimate being $0.26. While investors closely watch year-over-year changes in headline numbers -- revenue ...